Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα and cell-cycle signaling in a breast cancer model

Kate M Moore, Vera Cerqueria, Kenneth Macleod, Peter Mullen, Larry Hayward, Simon Green, David J. Harrison, David A Cameron, Simon P Langdon

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalExploration of Targeted Anti-tumor Therapy
Publication statusPublished - 28 Feb 2022

Cite this